[
  {
    "ts": "2025-09-16T18:58:22+00:00",
    "headline": "What Does Wall Street Think About Bristol-Myers Squibb (BMY)?",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best drug stocks to buy right now. On September 8, BMO Capital analyst Evan Seigerman maintained a Hold rating on Bristol-Myers Squibb Company (NYSE:BMY), retaining the price target of $47.00. The analyst attributed the rating to the performance of Cobenfy, the company’s new product, in the market, […]",
    "url": "https://finance.yahoo.com/news/does-wall-street-think-bristol-185822084.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "3c767665-3463-3219-b4d6-547abc202650",
      "content": {
        "id": "3c767665-3463-3219-b4d6-547abc202650",
        "contentType": "STORY",
        "title": "What Does Wall Street Think About Bristol-Myers Squibb (BMY)?",
        "description": "",
        "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best drug stocks to buy right now. On September 8, BMO Capital analyst Evan Seigerman maintained a Hold rating on Bristol-Myers Squibb Company (NYSE:BMY), retaining the price target of $47.00. The analyst attributed the rating to the performance of Cobenfy, the company’s new product, in the market, […]",
        "pubDate": "2025-09-16T18:58:22Z",
        "displayTime": "2025-09-16T18:58:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Why Investors View Bristol‑Myers Squibb (BMY) as a Safe Dividend Stock for Income",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w_.mq2hxLlg_y2nUTx72ng--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t6o8Kx8kFVS_oEolQVNGNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/does-wall-street-think-bristol-185822084.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/does-wall-street-think-bristol-185822084.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-16T13:27:57+00:00",
    "headline": "Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction",
    "summary": "In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Bristol-Myers Squibb Company stands fifth among them. Bristol-Myers Squibb Company (NYSE:BMY), a global biopharmaceutical leader, specializes in oncology, immunology, cardiovascular, hematology, and neuroscience therapies, with blockbuster drugs including Eliquis and Opdivo. In July 2025, Bristol-Myers Squibb Company (NYSE:BMY) […]",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-132757502.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9b202c4e-7f06-37bc-b022-3933881c13fa",
      "content": {
        "id": "9b202c4e-7f06-37bc-b022-3933881c13fa",
        "contentType": "STORY",
        "title": "Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction",
        "description": "",
        "summary": "In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Bristol-Myers Squibb Company stands fifth among them. Bristol-Myers Squibb Company (NYSE:BMY), a global biopharmaceutical leader, specializes in oncology, immunology, cardiovascular, hematology, and neuroscience therapies, with blockbuster drugs including Eliquis and Opdivo. In July 2025, Bristol-Myers Squibb Company (NYSE:BMY) […]",
        "pubDate": "2025-09-16T13:27:57Z",
        "displayTime": "2025-09-16T13:27:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4b9ae3e820991409356264f5ee1180f1",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uyj2Rz57RH_ntM0L06zAjQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4b9ae3e820991409356264f5ee1180f1.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TwFme34d1nKxga1zEuJT5g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4b9ae3e820991409356264f5ee1180f1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-132757502.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-132757502.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "BNTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-16T13:00:08+00:00",
    "headline": "These 4 Measures Indicate That Bristol-Myers Squibb (NYSE:BMY) Is Using Debt Reasonably Well",
    "summary": "The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...",
    "url": "https://finance.yahoo.com/news/4-measures-indicate-bristol-myers-130008465.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "762dd1b5-47c2-3613-9172-38f367e40ad7",
      "content": {
        "id": "762dd1b5-47c2-3613-9172-38f367e40ad7",
        "contentType": "STORY",
        "title": "These 4 Measures Indicate That Bristol-Myers Squibb (NYSE:BMY) Is Using Debt Reasonably Well",
        "description": "",
        "summary": "The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...",
        "pubDate": "2025-09-16T13:00:08Z",
        "displayTime": "2025-09-16T13:00:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/isv7n73YBii.eJbbdO3fww--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRv2ZxXw0SbLt6U2idf4TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/4-measures-indicate-bristol-myers-130008465.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/4-measures-indicate-bristol-myers-130008465.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-16T11:00:00+00:00",
    "headline": "K36 Therapeutics Provides Clinical Update on KTX-1001 in Multiple Myeloma",
    "summary": "K36 Therapeutics, Inc. (\"K36\"), a privately held clinical-stage biotechnology company developing novel, targeted therapies for cancers with unmet medical need, today provided a clinical update on its lead asset, KTX-1001 for multiple myeloma (MM).",
    "url": "https://finance.yahoo.com/news/k36-therapeutics-provides-clinical-ktx-110000057.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "8237edf8-bfb1-3797-bddc-782fde20cb33",
      "content": {
        "id": "8237edf8-bfb1-3797-bddc-782fde20cb33",
        "contentType": "STORY",
        "title": "K36 Therapeutics Provides Clinical Update on KTX-1001 in Multiple Myeloma",
        "description": "",
        "summary": "K36 Therapeutics, Inc. (\"K36\"), a privately held clinical-stage biotechnology company developing novel, targeted therapies for cancers with unmet medical need, today provided a clinical update on its lead asset, KTX-1001 for multiple myeloma (MM).",
        "pubDate": "2025-09-16T11:00:00Z",
        "displayTime": "2025-09-16T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/ce5b97762406c844fccf90d734f721ee",
          "originalWidth": 400,
          "originalHeight": 275,
          "caption": "K36 logo (PRNewsfoto/K36 Therapeutics)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4e.GPbJCAlSDyipLu5bqQg--~B/aD0yNzU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ce5b97762406c844fccf90d734f721ee.cf.webp",
              "width": 400,
              "height": 275,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TPf74W7liRsz8BDJ92NX_A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ce5b97762406c844fccf90d734f721ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/k36-therapeutics-provides-clinical-ktx-110000057.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/k36-therapeutics-provides-clinical-ktx-110000057.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-16T10:59:00+00:00",
    "headline": "Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum",
    "summary": "PRINCETON, N.J., September 16, 2025--Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-participate-bernstein-105900334.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "20d6b792-440a-3579-8d5d-96c641d38a2a",
      "content": {
        "id": "20d6b792-440a-3579-8d5d-96c641d38a2a",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum",
        "description": "",
        "summary": "PRINCETON, N.J., September 16, 2025--Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum",
        "pubDate": "2025-09-16T10:59:00Z",
        "displayTime": "2025-09-16T10:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/343a949c6aa65bad466a6cbbca57a44e",
          "originalWidth": 1497,
          "originalHeight": 206,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4Ij0u8Q6au4bA9IFXGfaWg--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/343a949c6aa65bad466a6cbbca57a44e.cf.webp",
              "width": 1497,
              "height": 206,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3fjRgez5el3pfjLWHVqCdQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/343a949c6aa65bad466a6cbbca57a44e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-participate-bernstein-105900334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-participate-bernstein-105900334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]